Rituximab on lung, skin, and joint involvement in patients with systemic sclerosis: A case series study and review of the literature.
Handan Y TuğsalBerrin ZenginGökce KenarFatoş ÖnenAhmet Merih BirlikPublished in: International journal of rheumatic diseases (2022)
This study suggests that RTX is effective for arthritis in patients with SSc. Also, the effectiveness of RTX in skin and lung involvement of SSc was predominantly toward stable disease or improvement. Despite the long disease duration, the presence of patients who showed improvement in skin and lung involvement after RTX treatment suggests the need to investigate predictors of RTX response.